［1］Verschakelen JA，Wever WD，Matamoros A.Computed tomography of the lung：A pattern approach［J］.Journal of Nuclear Medicine，2007，49(1)：164.
［2］Naidich DP，Bankier AA，MacMahon H，et al.Recommendations for the management of subsolid pulmonary nodules detected at CT：A statement from the Fleischner Society［J］.Radiology，2012，266(1)：304-317.
［3］Lee HY，Choi YL，Lee KS，et al.Pure ground-glass opacity neoplastic lung nodules：Histopathology，imaging，and management［J］. American Journal of Roentgenology，2014，202(3)：224-233.
［4］Asamura H，Hishida T，Suzuki K，et al.Radiographically determined noninvasive adenocarcinoma of the lung：Survival outcomes of the Japan Clinical Oncology Group 0201［J］.Journal of Thoracic & Cardiovascular Surgery，2013，146(1)：24-30.
［5］Ridge CA，Alexander A，Eisenberg B.Mosaic attenuation［J］.American Journal of Roentgenology，2011，197(6)：970-977.
［6］Liu SY.The current status of the management of pulmonary subsolid nodules in China［J］.Oncoradiology，2013，22(4)：288-291.［刘士远.肺内非实性结节的临床处理现状堪忧［J］.肿瘤影像学，2013，22(4)：288-291.］
［7］Kobayashi Y，Mitsudomi T，Li WY.The management of grand-glass opacity：Should all grand-glass opacitys be surgically removed［J］?Journal of Pathology and Clinical Medicine，2014，34(3)：225-233.［Kobayashi Y，Mitsudomi T，李文雅，毛玻璃样病变的处理：是否所有肺部毛玻璃样病变都应手术切除［J］?临床与病理杂志，2014，34(3)：225-233.］
［8］Kadota K，Villena-Vargas J，Yoshizawa A，et al.Prognostic significance of adenocarcinoma in situ，minimally invasive adenocarcinoma，and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease［J］.Am J Surg Pathol，2014，38：448-460.
［9］Tsutani Y，Miyata Y，Nakayama H，et al.Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma：A multicenter study［J］.J Thorac Cardiovasc Surg，2012，143：607-612.
［10］Warth A，Muley T，Meister M，et al.The novel histologic international association for the study of lung cancer/American thoracic society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival［J］.J Clin Oncol，2012，30：1438-1446.
［11］Yoshizawa A，Sumiyoshi S，Sonobe M，et al.Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations：Analysis of 440 Japanese patients［J］.J Thorac Oncol，2013，8：52-61.
［12］Tsao MS，Marguet S，Le TG，et al.Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection［J］.J Clin Oncol，2015，33：3439-3446.
［13］Lim HJ，Ahn S，Lee KS，et al.Persistent pure ground-glass opacity lung nodules >/=10 mm in diameter at CT scan：Histopathologic comparisons and prognostic implications［J］.Chest，2013，144：1291-1299.
［14］Isaka T，Yokose T，Ito H，et al.Comparison between CT tumor size and pathological tumor size in frozen section examinations of lung adenocarcinoma［J］.Lung Cancer，2014，85：40-46.
［15］Baldwin DR，Callister MJ.The british thoracic society guidelines on the investigation and management of pulmonary nodules［J］.Thorax，2015，70：794-798.
［16］Hiramatsu M，Inagaki T，Inagaki T，et al.Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth［J］.J Thorac Oncol，2008，3(11)：1245-1250.
［17］Kobayashi Y，Sakao Y，Deshpande GA，et al.The association between baselineclinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity［J］.Lung Cancer，2014，83：61-66.
［18］Lee SW，Leem CS，Kim TJ，et al.The long-term course of ground-glass opacities detected on thin-section computed tomography［J］.Respir Med，2013，107：904-910.
［19］McWilliams A，Tammemagi MC，Mayo JR，et al.Probability of cancer in pulmonary nodules detected on first screening CT［J］.N Engl J Med，2013，36（21）：910-919.
［20］Wood DE.National cmprehensive cncer ntwork (NCCN) clinical practice guidelines for lung cancer screening［J］.Thorac Surg Clin，2015，25：185-197.
［21］De HB，Gietema H，Van DVS，et al.Pulmonary ground-glass nodules：Increase in mass as an early indicator of growth［J］.Radiology，2010，255（1）：199-206.
［22］Veronesi G，Travaini LL，Maisonneuve P，et al.Positron emission tomography in the diagnostic work-up of screening-detected lung nodules［J］.Eur Respir J，2015，45：501-510.
［23］Finley RJ，Mayo JR，Grant K，et al.Preoperative computed tomography-guided microcoil localization of small peripheral pulmonary nodules：A prospective randomized controlled trial［J］.J Thorac Cardiovasc Surg，2015，149：26-32.
［24］McConnell PI，Feola GP，Meyers RI.Methylene blue-stained autologous blood for needle localization and thoracoscopic resection of deep pulmonary nodules［J］.J Pediatr Surg，2002，37（12）：1729-1731.
［25］Khereba M，Ferraro P，Duranceau A，et al.Thoracoscopic localization of intraparenchymal pulmonary nodules using direct intracavitary thoracoscopic ultrasonography prevents conversion of VATS procedures to thoracotomy in selected patients［J］.J Thorac Cardiovasc Surg，2012，144（5）：1160-1165.
［26］Mioyoshi K，Toyooka S，Gobara H，et al.Clinical outcomes of a short hook wire and suture marking system in thoracoscopic resection for pulmonary nodules［J］.Eur J Cardiothorac Surg，2009，36：378-382.
［27］Watanabe K，Nomori H，Ohtsuka T，et al.Usefulness and complications of computed tomography-guided lipiodol making for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules：Experience with 174 nodules［J］.J Thorac Cardiovasc Surg，2006，132：320-324.
［28］Gonfiotti A，Davini E，Vaggelli L，et al.Thoracoscopic localization techniques for patients with solitary pulmonary nodules：Hookwire versus radio-guided surgery［J］.Eur J Cardiothorac Surg，2007，32（6）：843-847.
［29］Petersen RH，Hansen HJ，Dirksen A，et al.Lung cancer screening and video-assisted thoracic surgery［J］.J Thorac Oncol，2012，7：1026-1031.
［30］Lim E，Baldwin D，Beckles M，et al.Guidelines on the radical management of patients with lung cancer［J］.Thorax，2010，65 suppl 3(7)：1-27.
［31］Suzuki K，Kusumoto M，Watanabe S，et al.Radiological classification of small adenocarcinoma of the lung：Radiologic-pathologic correlation and its prognostic impact［J］.Ann Thorac Surg，2006，81：413-419.
［32］Field JK，Smith RA，Aberle DR，et al.International association for the study of lung cancer computed tomography screening workshop 2011 report［J］.J Thorac Oncol，2012，7：10-19.
［33］Tsutani Y，Miyata Y，Nakayama H，et al.Oncological outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma：Propensity score-matched analysis in a multicenter study［J］.J Thorac Cardiovasc Surg，2013，146：358-364.
［34］Tsutani Y，Miyata Y，Nakayama H，et al.Appropriate sublobar resection choice ground glass opacity-dominant clinical stage Ⅰa adenocarcinoma：Wedge resection or segmentectomy［J］.Chest，2014，145：66-71.
［35］Sakurai H，Asamura H.Sublobar resection for early-stage lung cancer［J］.Transl Lung Cancer Res，2014，3：164-172.